BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells

Hu,Min; Cui,Facai; Liu,Fengzhen; Wang,Jinlin; Wei,Xiaoxia; Li,Yi

doi:10.3892/ijo.2016.3802

BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells

Authors:
- Min Hu
- Facai Cui
- Fengzhen Liu
- Jinlin Wang
- Xiaoxia Wei
- Yi Li
View Affiliations

Affiliations: Clinical Biochemistry Laboratory, Medical Diagnostic Department of Henan Provincial People's Hospital, Zhengzhou, Henan 450000, P.R. China
Published online on: December 12, 2016 https://doi.org/10.3892/ijo.2016.3802
Pages: 193-202

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone morphogenetic proteins (BMPs) are broadly involved in normal embryo development and abnormal pathological process such as cancer. The complexity and diversity of BMPs and their signaling pathways impose quite different or even conflicting effects on clinical traits of tumors. The aim of the present study was to investigate whether different BMPs, including BMP2, BMP4, BMP6 and BMP7, influence esophageal squamous cancer cell (ESCC) growth, invasion and metastasis. BMP6 and type I receptor ALK2 and type II receptor BMPRII, ActRIIA and ActRIIB were expressed in all ESCC cell lines. In addition, adenovirus-mediated BMP overexpression did not affect ECA-109 cell growth. BMP6/7 overexpression increased ECA-109 cell invasion and metastasis, activated SMAD1/5/8 signal pathway and induced downstream gene ID1 expression. While BMP2/4 overexpression reduced ECA-109 cell invasion and metastasis and obviously promoted ERK1/2, P-38 and JNK activation with weak SMAD1/5/8 phosphorylation. When BMP6/7 favorite type I receptor ALK2 or type II receptor BMPRII was interfered with by dominant-negative mutation, BMP6/7-induced invasion and metastasis augmentation disappeared. Further investigation on clinical ESCC samples and non-tumorous adjacent tissue found that tumors with triple-positive BMP6, ALK2 and BMPRII had deeper growth than tumors with only BMP6 expression. These results suggested that different BMPs distinctly affected esophageal squamous cancer cell invasion and metastasis by employing different signal pathways.

View Figures

View References

1	Rees JR, Onwuegbusi BA, Save VE, Alderson D and Fitzgerald RC: In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res. 66:9583–9590. 2006. View Article : Google Scholar : PubMed/NCBI
2	Chen D, Zhao M and Mundy GR: Bone morphogenetic proteins. Growth Factors. 22:233–241. 2004. View Article : Google Scholar : PubMed/NCBI
3	Yang S, Du J, Wang Z, Yuan W, Qiao Y, Zhang M, Zhang J, Gao S, Yin J, Sun B, et al: BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer. 7:2112007. View Article : Google Scholar : PubMed/NCBI
4	Shepherd TG and Nachtigal MW: Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology. 144:3306–3314. 2003. View Article : Google Scholar : PubMed/NCBI
5	Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK and Morton RA: Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res. 60:2840–2844. 2000.PubMed/NCBI
6	Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA and Wozney JM: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA. 87:9843–9847. 1990. View Article : Google Scholar : PubMed/NCBI
7	Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K and Imamura T: Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci. 112:3519–3527. 1999.PubMed/NCBI
8	Park Y, Kim JW, Kim DS, Kim EB, Park SJ, Park JY, Choi WS, Song JG, Seo HY, Oh SC, et al: The bone morphogenesis protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer. Cancer Res Treat. 40:127–132. 2008. View Article : Google Scholar
9	Rothhammer T, Poser I, Soncin F, Bataille F, Moser M and Bosserhoff AK: Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65:448–456. 2005.PubMed/NCBI
10	Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P and Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis. 24:1445–1454. 2003. View Article : Google Scholar : PubMed/NCBI
11	Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T and Terada M: Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res. 57:5022–5027. 1997.PubMed/NCBI
12	Thériault BL, Shepherd TG, Mujoomdar ML and Nachtigal MW: BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis. 28:1153–1162. 2007. View Article : Google Scholar : PubMed/NCBI
13	Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, Rosmolen WD, Bergman JJ, VAn Marle J, Wang KK, et al: Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 132:2412–2421. 2007. View Article : Google Scholar : PubMed/NCBI
14	Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH and Park JH: Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci. 100:2218–2225. 2009. View Article : Google Scholar : PubMed/NCBI
15	Alarmo EL, Korhonen T, Kuukasjärvi T, Huhtala H, Holli K and Kallioniemi A: Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol. 19:308–314. 2008. View Article : Google Scholar
16	Lim M, Chuong CM and Roy-Burman P: PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures. Horm Cancer. 2:298–309. 2011. View Article : Google Scholar : PubMed/NCBI
17	Chen X, Liao J, Lu Y, Duan X and Sun W: Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Pathol Oncol Res. 17:257–261. 2011. View Article : Google Scholar
18	Augeri DJ, Langenfeld E, Castle M, Gilleran JA and Langenfeld J: Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer. 15:272016. View Article : Google Scholar
19	Yuen HF, McCrudden CM, Grills C, Zhang SD, Huang YH, Chan KK, Chan YP, Wong ML, Law S, Srivastava G, et al: Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression. Cancer Sci. 103:1145–1154. 2012. View Article : Google Scholar : PubMed/NCBI
20	Megumi K, Ishigami S, Uchikado Y, Kita Y, Okumura H, Matsumoto M, Uenosono Y, Arigami T, Kijima Y, Kitazono M, et al: Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma. Ann Surg Oncol. 19:2066–2071. 2012. View Article : Google Scholar :
21	Hu M, Liu Q, Song P, Zhan X, Luo M, Liu C, Yang D, Cai Y, Zhang F, Jiang F, et al: Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells. Oncol Rep. 29:185–192. 2013.
22	Pickup MW, Hover LD, Guo Y, Gorska AE, Chytil A, Novitskiy SV, Moses HL and Owens P: Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 6:22890–22904. 2015. View Article : Google Scholar : PubMed/NCBI
23	Langenfeld E, Hong CC, Lanke G and Langenfeld J: Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One. 8:e612562013. View Article : Google Scholar : PubMed/NCBI
24	Wahdan-Alaswad RS, Song K, Krebs TL, Shola DT, Gomez JA, Matsuyama S and Danielpour D: Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res. 70:9106–9117. 2010. View Article : Google Scholar : PubMed/NCBI
25	Kim SM, Ye S, Rah SY, Park BH, Wang H, Kim JR, Kim SH, Jang KY and Lee KB: RhBMP-2 activates hippo signaling through RASSF1 in esophageal cancer cells. Sci Rep. 6:268212016. View Article : Google Scholar : PubMed/NCBI
26	Kokorina NA, Zakharkin SO, Krebsbach PH and Nussenbaum B: Treatment effects of rhBMP-2 on invasiveness of oral carcinoma cell lines. Laryngoscope. 121:1876–1880. 2011.PubMed/NCBI
27	Peng J, Yoshioka Y, Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Kharma B, Murakami R, Abiko K, et al: The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target. Mol Carcinog. 55:335–345. 2016. View Article : Google Scholar
28	Chen JC, Yang ST, Lin CY, Hsu CJ, Tsai CH, Su JL and Tang CH: BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells. PLoS One. 9:e1126362014. View Article : Google Scholar
29	Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X and Chan KW: Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 97:1409–1415. 2007. View Article : Google Scholar : PubMed/NCBI
30	Hao J, Lee R, Chang A, Fan J, Labib C, Parsa C, Orlando R, Andresen B and Huang Y: DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer. PLoS One. 9:e907482014. View Article : Google Scholar : PubMed/NCBI
31	Herrera B, van Dinther M, Ten Dijke P and Inman GJ: Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res. 69:9254–9262. 2009. View Article : Google Scholar : PubMed/NCBI
32	Lavery K, Swain P, Falb D and Alaoui-Ismaili MH: BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem. 283:20948–20958. 2008. View Article : Google Scholar : PubMed/NCBI
33	Jung JW, Yoon SM, Kim S, Jeon YH, Yoon BH, Yang SG, Kim MK, Choe S and Kuo MM: Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population. Oncotarget. Sep 16–2016.Epub ahead of print. View Article : Google Scholar
34	Zhou Q, Heinke J, Vargas A, Winnik S, Krauss T, Bode C, Patterson C and Moser M: ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res. 76:390–399. 2007. View Article : Google Scholar : PubMed/NCBI
35	Jiang M, Ku WY, Zhou Z, Dellon ES, Falk GW, Nakagawa H, Wang ML, Liu K, Wang J, Katzka DA, et al: BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. J Clin Invest. 125:1557–1568. 2015. View Article : Google Scholar : PubMed/NCBI
36	Zhang L, Sun H, Zhao F, Lu P, Ge C, Li H, Hou H, Yan M, Chen T, Jiang G, et al: BMP4 administration induces differentiation of CD133⁺ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. Cancer Res. 72:4276–4285. 2012. View Article : Google Scholar : PubMed/NCBI